OpenAlex 5,542 works 206 author topics
Works
5,542 works
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 100.0%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 100.0%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 100.0%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.9%
BACKGROUND: The efficacy and safety of the anti-programmed death ligand 1 (PD-L1) monoclonal antibody atezolizumab, as compared with those of platinum-based chemotherapy, as first-line treatment for patients with metastatic non-small-cell lung cancer (NSCLC) with PD-L1 expression are not known. METHODS: wild-type tumo…
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.8%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.8%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.8%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 96.1%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 10%
OpenAlex 96.1%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.8%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.9%
No abstract yet.
-
YÖKSİS
SJR Q1
JCR Q1
OpenAlex top 1%
OpenAlex 99.4%
No abstract yet.
Academicians
206 academicians
- ALBERT GÜVENİŞ 49 author topics
- DENİZ ESİN TEKCAN ŞANLI 35 author topics
- ESİN ÖZTÜRK IŞIK 35 author topics
- NAZE DENİZ DOĞAN 29 author topics
- GÖKHAN BİLGİN 26 author topics
- ALP DİNÇER 25 author topics
- KORAY ÖZDUMAN 24 author topics
- MEDİNE BÖGE 24 author topics
- AYÇA ERŞEN DANYELİ 22 author topics
- AKİF TURNA 17 author topics
- ELGİN ÖZKAN 17 author topics
- İSHAK PAÇAL 17 author topics